References
- Feily A, Namazi MR, Saboktakin M, Daneshpajuh F, Mehri M, Lotfi J. L-carnitin: a potential treatment for hyper-IgE syndrome. G Ital Dermatol Venereol. 2009 Apr;144(2):214.
- Grimbacher B, Holland SM, Gallin JI et al. Hyper IgE syndrome with recurrent infections—an autosomal dominant multisystem disorder. N Eng J Med 1999;340:692–702.
- Donabedian H, Gallin JI. Two inhibitors of neutrophil chemotaxis are produced by hyper immunoglobulin E-recurrent infection syndrome mononuclear cells exposed to head-killed staphylococci. Infect Immune 1983;40:1030–7.
- Aihara Y, Mori M, Yokota S. Successful treatment of onychomycosis with fluconazole in two patients with hyperimmunoglobulinemia E syndrome. Pediatr Dermatol 1996;13:493–5.
- Gennery AR, Flood TJ, Abinun M, Cant AJ. Bone marrow transplantation does not correct the hyper IgE syndrome. Bone Marrow Transplant 2000;25:1303–5.
- Sanal O, Göçmen A, Tezcan I, Ersoy F, Adalioğlu G. Hyper-IgE syndrome: a case report. Turk J Pediatr 1990 Oct–Dec;32(4):273–8.
- http://medical-dictionary.thefreedictionary.com/inosiplex. Accessed 23 May 2009.
- Tsang KY, Pan JF, Swanger DL, Fudenberg HH. In vitro restoration of immune responses in aging humans by isoprinosine. Int J Immunopharmacol. 1985;7(2):199–206.
- Azzarà A, Polidori R, Petrini M, Margelli M, Vatteroni ML, Grassi B, et al. Methisoprinol restoration of leukocyte chemotaxis inhibition by blocking factors in immunoproliferative diseases. Int J Tissue React 1984;6(4):303–10.
- Ricevuti G, Mazzone A, Baiguera R [Effect of methisoprinol on neutrophil functions in patients with rheumatoid arthritis. Minerva Med. 1985 Oct 27;76(41):1945–50.
- Hersey P, Bindon C, Bradley M, Hasic E. Effect of Isoprinosine on interleukin 1 and 2 production and on suppressor cell activity in pokeweed mitogen stimulated cultures of B and T cells. Int J Immunopharmacol 1984;6(4):321–8.